Copyright © Inderes 2011 - present. All rights reserved.

Remedy Entertainment

13.3

 

EUR

 

-0.75 %

Corporate customer

REMEDY

NASDAQ Helsinki

Software

Technology

11,233 following
Compare
-0.75%
+3.1%
-21.21%
-24.69%
-47.64%
-44.81%
-62.05%
+20.36%
+98.8%

Remedy Entertainment is a game developer. The business is primarily focused on the development of action games, with a particular focus on 3D technology. Examples of games developed by the company include several different versions of Alan Wake, Max Payne, and Control. Remedy also develops its own game engine and utility technology that powers many of the games. The company was founded in 1995 and has its headquarters in Espoo.

Read more
Market cap
180.54M EUR
Turnover
320.52K EUR
P/E (adj.) (24e)
-32.09
EV/EBIT (adj.) (24e)
-24.47
P/B (24e)
2.91
EV/S (24e)
3.59
Dividend yield-% (24e)
-
Coverage
Recommendation
Buy
Target price
19.00 EUR
Updated
2024-12-17
Disclaimer
Latest research

Latest analysis report

Released: 2024-11-20

Latest extensive report

Released: 2024-12-18

Financial calendar
12/2
2025

Annual report '24

10/4
2025

General meeting '24

30/4
2025

Business review Q1'25

Risk
Business risk
Valuation risk
Low
High
ShowingAll content types
Extensive research by
Atte Riikola

Remedy extensive report: No game, no fame

Over the years, Remedy has demonstrated its ability to develop games of very high quality, but this has not yet been reflected to the same extent in their commercial success for the company. As a result of years of work, the company has built its capabilities and resources to support a more frequent, even annual pace of new game releases over the 2025-2030 strategy period.

Remedy Entertainment

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Research by
Atte Riikola

Remedy Q3'24: Long-term potential is building

The company's Q3 results were well above expectations and the game projects in development are progressing well. However, the sales performance of Alan Wake 2 has been disappointing compared to our expectations, and the company now has something to prove during the crucial sales months at the end of the year.

Remedy Entertainment
Remedy Q3'24 flash comment: Figures above expectations, but AW2 sales development disappointing
Analyst Comment by
Atte Riikola

Remedy Q3'24 flash comment: Figures above expectations, but AW2 sales development disappointing

Remedy reported significantly stronger Q3 figures this morning than we expected, as more development fees from the Control 2 project were recognized in the quarter than we anticipated. The company's game projects are also progressing in line with our expectations. On the negative side, Alan Wake 2 has not yet recouped its development and marketing budget, and now sales expectations are focused on the crucial November-December window.

Remedy Entertainment
Forum discussions
Inför Q1 från Remedy på måndag. Inderes Remedy Q1 on Monday: Our forecast sees AW2 royalties only starting to show in... Remedy will report its Q1 results on Monday at 9.00 am EEST. We will review the report afresh in Remedy earnings live starting at 8.55 am (in Finnish). We still...
4/23/2024, 9:15 AM
by Jesper Hagman
4
Här är analytikern @Atte_Riikola:s kommentarer om de senaste nyheterna från det här intressanta finska spelföretaget. Remedy announced on Thursday a strategic partnership agreement with Annapurna Pictures for Control 2. Remedy will self-publish the game, but Annapurna will fund 50...
8/31/2024, 12:16 PM
by börsen84
2
BREAKING NEWS FROM REMEDY!!! Inderes Remedy acquires full rights to the Control franchise from 505 Games at a good... We see the agreement as very positive for Remedy's long-term potential, as the company is now in a strong position to decide to self-publish future Control games ...
2/29/2024, 9:21 PM
by börsen84
2
Det här är en analys gjord efter Remedys tredje kvartal som är av hög kvalitet och både lättläst och lätt att förstå på ett omfattande sätt. Inderes Remedy Q3'24: Long-term potential is building - Inderes The company's Q3 results were well above expectations and the game projects...
11/4/2024, 10:02 AM
by börsen84
1
Remedys resultat för tredje kvartalet var starkare än väntat, särskilt tack vare utvecklingsavgifterna från Control 2-projektet. Företagets spelprojekt fortskrider enligt planerna, men Alan Wake 2 har ännu inte täckt sina utvecklings- och marknadsföringskostnader. Detta ökar pressen...
11/3/2024, 10:07 AM
by börsen84
1
Remedy Q4 onsdag: AW2-royalties och publiceringskontrakt för Control-spel medför fluktuationer i 2024 års siffror. Inderes Remedy Q4 next Wednesday: AW2 royalties and Control games' publishing... Remedy will report its Q4 results next Wednesday at 9.00 am EET. With the profit warning...
3/18/2024, 9:50 PM
by börsen84
1
Inderes upprepar sin Köp-rekommendation och riktkursen på 19 euro för Remedy. Remedy har visat sin förmåga att skapa högkvalitativa spel, men den kommersiella framgången har hittills varit blygsam. Bolaget siktar på en årlig utgivningstakt under strategiperioden 2025–2030 och planerar...
12/18/2024, 2:24 PM
by börsen84
0
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.